VIS reaffirms Macter International’s long-term rating at A

News Image

MG News | November 19, 2026 at 03:32 PM GMT+05:00

November 19, 2026 (MLN): Macter International Limited’s (PSX:MACTER) entity ratings have been reaffirmed at ‘A/A1’ (Single A/A-One) by VIS Credit Rating Company Limited (VIS), with the outlook remaining ‘Stable’.

The previous rating action was taken on September 29, 2025.

The medium to long-term rating of ‘A’ reflects good credit quality with adequate protection factors, though risk factors may vary with changes in the economy.

The short-term rating of ‘A1’ points to a strong likelihood of timely repayment of short-term obligations, backed by excellent liquidity factors.

VIS said the ratings draw support from the company’s conservative capital structure and stable earnings, which have underpinned strong debt coverages over the years, along with the relatively inelastic demand profile of the pharmaceutical sector.

Net sales grew 18.33% to Rs 11.7bn in FY26, while gross margin improved to 48.25% from 44.69% in FY25, on a better sales mix and a higher contribution from the prescription and export segments. The ratings also take into account the company’s expansion into biosimilars/biologicals and specialty injectables, including GLP-1 products.

The ratings, however, remain constrained by a moderation in net margin to 5.95% from 7.44% in FY25, due to higher selling and distribution expenses on strategic investments in new launches and growth, as well as finance costs and tax charge.

Working capital requirements have risen, with the cash conversion cycle lengthening to 83 days from 70 days and borrowings increasing to Rs 1.04bn.

This has weakened, though still kept adequate, debt coverages, with funds from operations (FFO) to total debt at 109% and debt service coverage ratio (DSCR) at 3.03x.

Product and client concentration have also increased, and the company remains exposed to exchange rate movements and international prices of imported active pharmaceutical ingredients (APIs).

Going forward, VIS said the ratings will remain sensitive to the rationalization of working capital, sustained debt-servicing coverage and margin stability amid sector volatility.

Incorporated in 1992, Macter is a listed public limited company based in Karachi. It manufactures and markets pharmaceutical products mainly through branded generics, with toll and contract manufacturing undertaken on a limited basis.

The company maintains dedicated facilities for cephalosporins, penicillins and biologics, in compliance with international cGMP and ISO standards.

 

Copyright Mettis Link News

 

 

 

 

 

 

Related News

Name Price/Vol %Chg/NChg
KSE100 176,772.19
128.70M
0.27%
477.86
ALLSHR 106,148.11
722.29M
0.19%
205.24
KSE30 51,576.50
51.44M
0.36%
183.11
KMI30 254,174.09
65.97M
0.62%
1564.51
KMIALLSHR 68,711.78
239.39M
0.28%
189.07
BKTi 48,323.13
9.35M
-0.17%
-81.19
OGTi 35,806.38
3.38M
0.27%
98.11
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 63,775.00 63,860.00
61,820.00
1260.00
2.02%
BRENT CRUDE 92.55 93.09
91.21
0.60
0.65%
RICHARDS BAY COAL MONTHLY 127.15 0.00
0.00
1.35
1.07%
ROTTERDAM COAL MONTHLY 131.75 131.75
131.75
0.00
0.00%
USD RBD PALM OLEIN 1,182.50 1,182.50
1,182.50
0.00
0.00%
CRUDE OIL - WTI 82.72 83.11
81.69
0.41
0.50%
SUGAR #11 WORLD 18.02 18.17
17.90
-0.02
-0.11%

Chart of the Day


Latest News
November 19, 2026 at 03:32 PM GMT+05:00

VIS reaffirms Macter International’s long-term rating at A


November 19, 2026 at 02:48 PM GMT+05:00

Oil steady amid supply glut fears, rate hike bets


November 19, 2026 at 02:47 PM GMT+05:00

Pakistan LSMI rises 3% MoM in September



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg